Jiang, Lijuan, Qiu, Wenlin, Wang, Xuefei, Duan, Xiaoru, Han, Xiaoxiao, Yu, Tong, Wen, Shenghui, Luo, Zhijun, Feng, Ruizhi, Teng, Yao et al (show 3 more authors)
(2023)
Immunoglobulin G inhibits glucocorticoid-induced osteoporosis through occupation of FcγRI.
iScience, 26 (10).
107749-.
Abstract
Glucocorticoid-induced osteoporosis (GIOP) is a severe and common complication of long-term usage of glucocorticoids (GCs) and lacks of efficient therapy. Here, we investigated the mechanism of anti-inflammation effect and osteoclastogenesis side effect of GCs and immunoglobulin G (IgG) treatment against GIOP. GCs inhibited SLE IgG-induced inflammation, while IgG inhibited GCs-induced osteoclastogenesis. FcγRI and glucocorticoid receptor (GR) were found directly interacted with each other. GCs and IgG could reduce the expression of FcγRI on macrophages. The deficiency of FcγRI affected osteoclastogenesis by GCs and systemic lupus erythematosus (SLE) IgG-induced inflammation. Also, IgG efficiently reduced GIOP in mice. These data showed that GCs could induce osteoporosis and inhibit IgG-induced inflammation through FcγRI while IgG efficiently suppressed osteoporosis induced by GCs through FcγRI. Hence, our findings may help in developing a feasible therapeutic strategy against osteoporosis, such as GIOP.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | Cell biology, Immunology, Molecular biology |
| Divisions: | Faculty of Health and Life Sciences Faculty of Health and Life Sciences > Institute of Life Courses and Medical Sciences |
| Depositing User: | Symplectic Admin |
| Date Deposited: | 31 Jan 2024 11:50 |
| Last Modified: | 31 Jan 2024 11:50 |
| DOI: | 10.1016/j.isci.2023.107749 |
| Open Access URL: | https://doi.org/10.1016/j.isci.2023.107749 |
| Related URLs: | |
| URI: | https://livrepository.liverpool.ac.uk/id/eprint/3178196 |
Dimensions
Dimensions
